Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Sameer Ansar"'
Autor:
Timothy Mason, Sameer Ansar
Publikováno v:
Journal of the Endocrine Society. 6:A307-A307
Background SGLT-2 inhibitors have been associated with increased risk of ketoacidosis even with normal blood glucose levels. A ketogenic diet is a low-carb, high-fat diet which has recently gained popularity for weight loss by producing a state of ke
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9283c80b5b0687d4d604bddf2002b25f
https://doi.org/10.1210/jendso/bvac150.635
https://doi.org/10.1210/jendso/bvac150.635
Publikováno v:
Gastro Hep Advances, Vol 3, Iss 3, Pp 396-398 (2024)
Hemangiomas in the gastrointestinal tract are extremely rare, benign vascular tumors, known for their associated complication of bleeding. They are usually difficult to diagnose, despite the characteristic definition of radiolucent phleboliths on rad
Externí odkaz:
https://doaj.org/article/84c83b14c06c4e30be766dd3df37cab1
Publikováno v:
Indian Dermatology Online Journal, Vol 15, Iss 3, Pp 546-548 (2023)
Externí odkaz:
https://doaj.org/article/849bea3af13f4b388d861173545f21e8
Autor:
Alison L. Cheah, Rooshdiya Z. Karim, Richard Boyle, Fiona Bonar, Peter P. Luk, Fiona Maclean, Sameer Ansar, Wendy Brown, Annabelle Mahar
Publikováno v:
Pathology. 52:S65
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9cbcaa62013253e52ae70c8ccb326be5
https://doi.org/10.1016/j.pathol.2020.01.210
https://doi.org/10.1016/j.pathol.2020.01.210
Autor:
Sameer Ansar, Jose Goldman, Bhavini Bhavsar, Ved V. Gossain, Matthew Hebdon, Archana Reddy, Saleh Aldasouqi
Publikováno v:
International Journal of Clinical Medicine. :751-757
Background: A recent study reported that some patients with diabetes who fast overnight for laboratory tests are at risk of developing hypoglycemia, which could occur while patients are in risky situations which could result in harm to patients or ot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::239cbb9ac9533129c52b06705992ea66
https://doi.org/10.4236/ijcm.2012.37a132
https://doi.org/10.4236/ijcm.2012.37a132
Publikováno v:
Infectious Diseases in Clinical Practice. 14:377-379
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::abeb724fda8e1e1e3f710ad6e1bd658d
https://doi.org/10.1097/01.idc.0000236975.58
https://doi.org/10.1097/01.idc.0000236975.58
Publikováno v:
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. 19(5)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::91f26830399d7ecac6e771c5ee130ee4
https://pubmed.ncbi.nlm.nih.gov/24014014
https://pubmed.ncbi.nlm.nih.gov/24014014
Publikováno v:
Journal of Diabetes & Metabolism.
Aim: Although insulin glargine is frequently being used in pregnancy, it is not approved by the FDA as the data on its safety is limited. The aim of this study was to determine the effects of insulin glargine use in pregnancy on maternal and fetal ou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c34f0ee05de3a6a30988123f4c14a716
https://doi.org/10.4172/2155-6156.1000240
https://doi.org/10.4172/2155-6156.1000240
Publikováno v:
Cardiovascular Diabetology, Vol 10, Iss 1, p 61 (2011)
Cardiovascular Diabetology
Cardiovascular Diabetology
Cardiovascular disease (CVD) risk in type 2 diabetes (T2DM) is only partially reduced by intensive glycemic control. Diabetic dyslipidemia is suggested to be an additional important contributor to CVD risk in T2DM. Multiple lipid lowering medications
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5545001f8c5c2a2de4cb7b5f2d21b4c7
https://doi.org/10.1186/1475-2840-10-61
https://doi.org/10.1186/1475-2840-10-61
Publikováno v:
Stroke: Vascular and Interventional Neurology, Vol 1, Iss S1 (2021)
Introduction: Intraluminal thrombosis after endovascular therapy (EVT) is a peri‐procedural complication that carries a high burden of morbidity and mortality. The use of anti‐thrombotic therapies during EVT remains an evolving field. Recent surv
Externí odkaz:
https://doaj.org/article/6a77360a60f34e04976a6cb4917f3a48